The spray – which was approved by the FDA in March – has a wholesale acquisition cost of $295 per 28 mg device and costs around $32,400 for a year’s treatment, says ICER.
Analysts at GlobalData have previously forecast that Spravato will generate global sales of approximately $383 million by 2029, with its potential pegged back by its cost and a requirement for two ...
When Dr. Husseini Manji was developing the first-in-class depression medication Spravato at Johnson & Johnson he encountered plenty of naysayers. “A lot of people didn’t think it would work ...
How Are Direct Costs and Variable Costs Different? Direct costs and variable costs are similar in nature and are both types of costs involved in production. Direct costs are expenses that can be ...
Two accounting terms this article will look at are transfer price and standard cost. While an item's standard cost can be used to determine its transfer price, the two values are inherently different.
U.S. NeuroStar Advanced Therapy System revenue for the three months ended September 30, 2024 was $4.1 million, an increase of 14% compared to $3.6 million in the third quarter of 2023. For the three ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
U.S. NeuroStar Advanced Therapy System revenue for the three months ended September 30, 2024 was $4.1 million, an increase of 14% compared to $3.6 million in the third quarter of 2023. For the three ...
2,000 Homeowners Surveyed We have conducted 2 surveys of 1000 homeowners to gather information on system cost across different providers and states, understand how consumers use incentives and ...